Augmedix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	46.34	21.38	41.38	23.15	11.78	10.04
Cash & Cash Equivalents	46.34	21.38	41.38	23.15	11.78	10.04
Cash Growth	116.79%	-48.34%	78.78%	96.54%	17.33%	-
Receivables	8.57	6.35	7.18	2.69	2.29	2.17
Other Current Assets	1.91	1.82	2.2	0.93	0.29	0.33
Total Current Assets	56.82	29.55	50.76	26.77	14.35	12.53
Property, Plant & Equipment	8.96	3.14	0.98	0.99	1.21	1.35
Long-Term Investments	0	0.61	0.21	0	0	0
Other Long-Term Assets	0.93	0.34	0.12	0.17	0.17	0.12
Total Long-Term Assets	9.89	4.09	1.31	1.17	1.39	1.47
Total Assets	66.71	33.64	52.07	27.94	15.74	14
Accounts Payable	0.72	1.56	1.37	0.26	0.64	0.27
Deferred Revenue	8.96	7.25	6.24	5.44	5.51	4.87
Current Debt	6.49	4.62	1.5	6.61	2.89	0.49
Other Current Liabilities	7.44	5.88	4.89	4.16	3.82	3.46
Total Current Liabilities	23.62	19.31	13.99	16.47	12.86	9.08
Long-Term Debt	19.35	12.35	13.34	8.34	9.72	13.15
Other Long-Term Liabilities	0.42	0.51	0.67	0	4.41	0.56
Total Long-Term Liabilities	19.77	12.86	14.01	8.34	14.13	13.71
Total Liabilities	43.39	32.18	28	24.81	27	22.8
Total Debt	25.85	16.97	14.84	14.95	12.62	13.65
Debt Growth	52.27%	14.40%	-0.76%	18.52%	-7.55%	-
Retained Earnings	-144.96	-125.79	-101.34	-83.88	-68.27	-49.78
Comprehensive Income	-0.92	-0.44	-0.07	-0.05	-0.04	-0.05
Shareholders' Equity	23.32	1.47	24.07	3.12	-65.14	-47.05
Net Cash / Debt	20.5	4.4	26.54	8.2	-0.84	-3.61
Net Cash / Debt Growth	365.61%	-83.42%	223.89%	-	-	-
Net Cash Per Share	0.47	0.12	0.92	1.17	-1.01	-3.03
Working Capital	33.21	10.24	36.77	10.3	1.49	3.45
Book Value Per Share	0.53	0.04	0.83	0.44	-78.33	-39.56

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).